Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIOREGENX, INC. | CEO, Interim CFO, Director, 10%+ Owner | Common | 198M | Mar 8, 2024 | Trustee of Wilshire Holdings Trust | ||
BIOREGENX, INC. | CEO, Interim CFO, Director, 10%+ Owner | Common | 20.7M | Mar 8, 2024 | Direct | ||
BIOREGENX, INC. | CEO, Interim CFO, Director, 10%+ Owner | Series A Preferred | 1.01K | Mar 8, 2024 | Trustee of Wilshire Holdings Trust | ||
BIOREGENX, INC. | CEO, Interim CFO, Director, 10%+ Owner | Series A Preferred | 112 | Mar 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FDIT | BIOREGENX, INC. | Mar 8, 2024 | 0 | $0 | 3 | May 22, 2024 | CEO, Interim CFO, Director, 10%+ Owner |